These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2148735)

  • 1. Clinical evaluation of chandonium iodide as a nondepolarising muscle relaxant.
    Kumar D; Bhatia VK; Yajnik S; Gaur SP; Nityanand S
    Indian J Med Res; 1990 Oct; 92():367-70. PubMed ID: 2148735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical evaluation of chandonium iodide and pancuronium bromide as muscle relaxant.
    Dasgupta D; Gupta KC; Vispute AV; Karandikar SM
    J Postgrad Med; 1990 Apr; 36(2):95-9. PubMed ID: 2151453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of chandonium iodide as muscle relaxant.
    Dasgupta D; D'Souza M; Shah SJ; Gupta KC; Satoskar RS
    Indian J Med Res; 1988 Mar; 87():298-302. PubMed ID: 3397166
    [No Abstract]   [Full Text] [Related]  

  • 4. Some actions of chandonium iodide, a new short-acting muscle relaxant, in anaesthetized cats and on isolated muscle preparations.
    Gandiha A; Marshall IG; Paul D; Rodger IW; Scott W; Singh H
    Clin Exp Pharmacol Physiol; 1975; 2(2):159-70. PubMed ID: 237641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
    Biró K; Kárpáti E
    Arzneimittelforschung; 1981; 31(11):1918-24. PubMed ID: 6172135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOSE RESPONSE RELATIONSHIP OF NEUROMUSCULAR BLOCKADE, INTUBATION CONDITIONS AND CARDIOVASCULAR CHANGES WITH CHANDONIUM IODIDE.
    Suri YV; Tripathi PC; Srimal RC; Gaur S; Dhawan BN
    Med J Armed Forces India; 1994 Jan; 50(1):37-43. PubMed ID: 28769159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical administration of muscle relaxants for intubation].
    Hofmockel R; Pohl B; Nöldge-Schomburg G
    Anaesthesiol Reanim; 2001; 26(5):116-22. PubMed ID: 11712228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Actions of chandonium iodide on skeletal muscle in culture.
    Harvey AL; Paul D; Singh H
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():62P. PubMed ID: 2738
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the time course of action of nondepolarizing neuromuscular blocking drugs (author's transl)].
    Schuh FT
    Anaesthesist; 1981 Sep; 30(9):440-6. PubMed ID: 6456677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients.
    Goldberg ME; Larijani GE; Azad SS; Sosis M; Seltzer JL; Ascher J; Weakly JN
    Anesth Analg; 1989 Jul; 69(1):93-9. PubMed ID: 2525886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients.
    Weber S; Brandom BW; Powers DM; Sarner JB; Woelfel SK; Cook DR; Foster VJ; McNulty BF; Weakly JN
    Anesth Analg; 1988 Jun; 67(6):495-9. PubMed ID: 2967644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.